The COVID-19 pandemic,caused by the SARS-CoV-2 virus,has brought about numerous challenges.One of these challenges is the impact of SARS-CoV-2 on the liver.Although this virus primarily affects the lungs,it can induce...The COVID-19 pandemic,caused by the SARS-CoV-2 virus,has brought about numerous challenges.One of these challenges is the impact of SARS-CoV-2 on the liver.Although this virus primarily affects the lungs,it can induce elevated transaminase levels and the development of scar tissue in the liver,exacerbating preexisting liver conditions.Individuals with preexisting conditions,such as nonalcoholic fatty liver disease,alcohol-induced liver disease and hepatocellular carcinoma,face an increased risk of mortality from COVID19.However,drugs currently used to treat COVID-19 have undesirable side effects,which make them unsuitable for patients with preexisting liver conditions.In this review,we explore the potential of phytochemicals,such as apigenin,berberine,curcumin,epigallocatechin-3-gallate,quercetin,resveratrol and silymarin,for treatment of the liver conditions,including nonalcoholic fatty liver disease,alcohol-induced liver disease and hepatocellular carcinoma.We also discuss significant associations between phytochemicals and COVID-19 by depicting their molecular interactions.Based on the discussed overlapping functions,it is important to assess the therapeutic efficacy of phytochemicals that possess hepatoprotective properties as potential alternative treatments for COVID-19.展开更多
文摘The COVID-19 pandemic,caused by the SARS-CoV-2 virus,has brought about numerous challenges.One of these challenges is the impact of SARS-CoV-2 on the liver.Although this virus primarily affects the lungs,it can induce elevated transaminase levels and the development of scar tissue in the liver,exacerbating preexisting liver conditions.Individuals with preexisting conditions,such as nonalcoholic fatty liver disease,alcohol-induced liver disease and hepatocellular carcinoma,face an increased risk of mortality from COVID19.However,drugs currently used to treat COVID-19 have undesirable side effects,which make them unsuitable for patients with preexisting liver conditions.In this review,we explore the potential of phytochemicals,such as apigenin,berberine,curcumin,epigallocatechin-3-gallate,quercetin,resveratrol and silymarin,for treatment of the liver conditions,including nonalcoholic fatty liver disease,alcohol-induced liver disease and hepatocellular carcinoma.We also discuss significant associations between phytochemicals and COVID-19 by depicting their molecular interactions.Based on the discussed overlapping functions,it is important to assess the therapeutic efficacy of phytochemicals that possess hepatoprotective properties as potential alternative treatments for COVID-19.
